{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:36:28Z","timestamp":1790890588665,"version":"4.1.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.leukres.2008.12.020","type":"journal-article","created":{"date-parts":[[2009,2,4]],"date-time":"2009-02-04T16:58:16Z","timestamp":1233766696000},"page":"1481-1484","source":"Crossref","is-referenced-by-count":143,"title":["Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis"],"prefix":"10.1016","volume":"33","author":[{"given":"Arturo","family":"Vega-Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge E.","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matjaz","family":"Sever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taghi","family":"Manshouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Quint\u00e1s-Cardama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Luthra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagop M.","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srdan","family":"Verstovsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2008.12.020_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000101711","article-title":"Mastocytosis: state of the art","volume":"74","author":"Horny","year":"2007","journal-title":"Pathobiology"},{"key":"10.1016\/j.leukres.2008.12.020_bib2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2174\/156800907781386614","article-title":"Kit: molecule of interest for the diagnosis and treatment of mastocytosis and other neoplastic disorders","volume":"7","author":"Patnaik","year":"2007","journal-title":"Curr Cancer Drug Target"},{"key":"10.1016\/j.leukres.2008.12.020_bib3","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identifications of mutations in the coding sequence of the proto-oncogen c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product","volume":"92","author":"Furitsu","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2008.12.020_bib4","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/cncr.22187","article-title":"Novel approaches in the treatment of systemic mastocytosis","volume":"107","author":"Quintas-Cardama","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2008.12.020_bib5","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood.V99.5.1741","article-title":"The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations","volume":"99","author":"Ma","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.12.020_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cncr.21996","article-title":"Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial","volume":"107","author":"Droogendijk","year":"2006","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.leukres.2008.12.020_bib7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2008.12.020_bib8","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1517\/14712598.7.10.1597","article-title":"Imatinib mesylate in the treatment of hematologic malignancies","volume":"7","author":"Piccaluga","year":"2007","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.leukres.2008.12.020_bib9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(03)14115-3","article-title":"Imatinib for systemic mast cell disease","volume":"362","author":"Pardanani","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2008.12.020_bib10","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","article-title":"A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib","volume":"103","author":"Akin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.12.020_bib11","first-page":"1115","article-title":"Juxtamembrane mutant V560Gkit is more sensitive to imatinib (STI571) compared with wild-type c-kit whereas the kinase mutant D816Vkit is resistant","volume":"1","author":"Frost","year":"2002","journal-title":"Mol Cancer Ther"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608005675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608005675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T02:51:46Z","timestamp":1545447106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212608005675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0145212608005675"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2008.12.020","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}